EFFECT OF SUBDERMAL LEVONORGESTREL CONTRACEPTIVE IMPLANTS, NORPLANT, ON SERUM-LIPIDS

被引:26
作者
SHAABAN, MM [1 ]
ELWAN, SI [1 ]
ABDALLA, SA [1 ]
DARWISH, HA [1 ]
机构
[1] UNIV ASSIUT, FAC MED, DEPT CLIN PATHOL, ASSIUT, EGYPT
关键词
D O I
10.1016/0010-7824(84)90033-7
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
引用
收藏
页码:413 / 419
页数:7
相关论文
共 21 条
[1]   EFFECTS OF CONTRACEPTIVE STEROIDS ON SERUM-LIPOPROTEINS AND CARDIOVASCULAR-DISEASE SCRUTINIZED AT WORKSHOP IN BETHESDA [J].
BAGGETT, B ;
NASH, HA .
CONTRACEPTION, 1980, 21 (02) :115-120
[2]  
BRADBY GVH, 1978, LANCET, V2, P1271
[3]   A RANDOMIZED STUDY OF METABOLIC EFFECTS OF 4 LOW-ESTROGEN ORAL-CONTRACEPTIVES .1. RESULTS AFTER 6 CYCLES [J].
BRIGGS, M ;
BRIGGS, M .
CONTRACEPTION, 1981, 23 (05) :463-471
[4]   CLINICAL-CHEMISTRY IN WOMEN TREATED WITH LEVONORGESTREL IMPLANTS (NORPLANT) OR A TCU-200 IUD [J].
CROXATTO, HB ;
DIAZ, S ;
ROBERTSON, DN ;
PAVEZ, M .
CONTRACEPTION, 1983, 27 (03) :281-288
[5]   A 5-YEAR CLINICAL-TRIAL OF LEVONORGESTREL SILASTIC IMPLANTS (NORPLANTTM) [J].
DIAZ, S ;
PAVEZ, M ;
MIRANDA, P ;
ROBERTSON, DN ;
SIVIN, I ;
CROXATTO, HB .
CONTRACEPTION, 1982, 25 (05) :447-456
[6]  
FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
[7]   HIGH-DENSITY LIPOPROTEIN AS A PROTECTIVE FACTOR AGAINST CORONARY HEART-DISEASE - FRAMINGHAM STUDY [J].
GORDON, T ;
CASTELLI, WP ;
HJORTLAND, MC ;
KANNEL, WB ;
DAWBER, TR .
AMERICAN JOURNAL OF MEDICINE, 1977, 62 (05) :707-714
[8]   THROMBOEMBOLIC DISEASE AND STEROIDAL CONTENT OF ORAL CONTRACEPTIVES - A REPORT TO COMMITTEE ON SAFETY OF DRUGS [J].
INMAN, WHW ;
VESSEY, MP ;
WESTERHOLM, B ;
ENGELUND, A .
BMJ-BRITISH MEDICAL JOURNAL, 1970, 2 (5703) :203-+
[9]  
INMAN WHW, 1980, LANCET 0524, P1118
[10]  
KNOPP RH, 1982, AM J OBSTET GYNECOL, V142, P725